Here are what the editors at HealthDay consider to be the most important developments in Dermatology for February 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Early Studies Often Show Exaggerated Treatment Effect
TUESDAY, Feb. 27, 2018 (HealthDay News) — Trials to evaluate drugs or devices used to treat chronic medical conditions that are published early in the chain of evidence often show an exaggerated treatment effect compared with subsequent trials, according to research published online Feb. 21 in the Mayo Clinical Proceedings.
Recommendations for Optimizing Hidden Curriculum in Medicine
MONDAY, Feb. 26, 2018 (HealthDay News) — In a position paper published online Feb. 27 in the Annals of Internal Medicine, the American College of Physicians (ACP) presents recommendations for optimizing clinical learning environments by fostering a positive hidden curriculum in medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Understanding Rx Nonadherence Can Improve Adherence
MONDAY, Feb. 26, 2018 (HealthDay News) — Understanding nonadherence in patients and encouraging a change in attitude toward patients and their medication can improve medication adherence, according to a report published by the American Medical Association (AMA).
Factors Tied to Molecular Testing by Dermatopathologists ID’d
MONDAY, Feb. 26, 2018 (HealthDay News) — Among dermatopathologists, relevant instruction during residency training, primary board certification in pathology, and academic medical center affiliation are among the factors associated with more frequent utilization of molecular testing, according to a study published online Feb. 13 in the Journal of Cutaneous Pathology.
Abstract/Full Text (subscription or payment may be required)
New Formulated Moisturizer Effective for Facial Dermatitis
FRIDAY, Feb. 23, 2018 (HealthDay News) — Facial moisturizers with specific ingredients may be effective for treating mild-to-moderate dermatitis, according to a study published online Feb. 6 in the Journal of Cosmetic Dermatology.
Abstract
Full Text (subscription or payment may be required)
FDA Warns of Possible Heart Risks Linked to Clarithromycin
FRIDAY, Feb. 23, 2018 (HealthDay News) — The antibiotic clarithromycin (brand name: Biaxin) may increase the long-term risk of heart problems and death in patients with heart disease, according to U.S. health officials.
Artificial Intelligence May Help Prevent Physician Burnout
FRIDAY, Feb. 23, 2018 (HealthDay News) — Artificial intelligence (AI), in which computers can be trained to recognize patterns in large quantities of data, may be able to reduce physicians’ burdens, saving them time and energy, according to a report published in Medical Economics.
Freshwater Swimming Tied to Stomach Bugs, Skin Conditions 
Considerable Global Disparities Found in Access to Dermatological Care 
Extreme Heat Linked to 33 Clinically Reportable Diagnoses 
Psoriasis Linked to Impairment of Some Sleep Domains 
Burden of Myocardial Dysfunction Elevated for Individuals With Psoriasis 
Dose Reduction of Biologics Effective, Safe for Psoriasis .jpg)
